High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
about
Cyclophosphamide for multiple sclerosisReduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosisA home-based walking program using rhythmic auditory stimulation improves gait performance in patients with multiple sclerosis: a pilot study.The safety profile of cyclophosphamide in multiple sclerosis therapy.Disease-modifying agents in multiple sclerosis.Promising treatments of tomorrow for multiple sclerosis.Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.Chemotherapeutics in the treatment of multiple sclerosis.Aggressive multiple sclerosis: proposed definition and treatment algorithm.Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis.Lights and shadows of cyclophosphamide in the treatment of multiple sclerosisHigh-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseasesA prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.Emerging therapies for multiple sclerosis.Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.High-dose chemotherapy and multiple sclerosis.Immunotherapy of multiple sclerosis: the state of the art.Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease.Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation.
P2860
Q24243160-81E0124F-45F3-4F8C-A1A7-9A06801146A9Q24647406-A6F4D7DD-6308-4DFB-BDF2-5D338B79D152Q30391613-9951BA3F-E9BD-4841-86F0-ECB6F531586CQ31105891-3E944CF7-D22A-4407-B392-A76F67D7EA7FQ33670940-4CFEA1C1-A4CC-40C7-9E6C-793ECABC5533Q33670947-1D2A212F-CCEE-49A8-96C0-C704AC40934AQ34409273-4786EE04-B443-4409-BA19-C23AD4E7BC98Q34409536-6F337A7B-3AE3-4E54-8179-1F2C889676EFQ34478828-E7CE7350-D257-49B1-86E7-1AE16F6FE8A7Q34630494-6B9577EB-3BBD-4A8D-A4C0-0AE3D6AB6D90Q34922742-7E63F93C-35E2-437A-A247-125A82B72993Q34986999-2D834480-464D-48C2-851A-32ACF3FA3F4BQ36075481-D50E5431-142D-48BF-BB3D-F882582942ABQ36730633-2042B44B-FA14-433B-B3EA-83524ADBF8E7Q36963208-013D5106-8549-41EB-B248-52E342643C3CQ37311065-9C8E6315-C422-4049-AA6D-276D34268E1CQ37822255-0706064C-D926-41CF-851B-94F586C00221Q38083041-EAD280F4-C621-43E3-951F-E167C07D46C8Q43130006-F1D3BCE2-F278-4191-940A-295FE562BAA2Q47962680-4CE0E52D-C72D-4004-9B5A-A8CE6B865299
P2860
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
@ast
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
@en
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
@nl
type
label
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
@ast
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
@en
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
@nl
prefLabel
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
@ast
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
@en
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
@nl
P2093
P1433
P1476
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
@en
P2093
Christopher Christodoulou
Douglas E Gladstone
Emily Locher
Kenneth W Zamkoff
Lauren Krupp
Patricia K Coyle
Patrick Sibony
Robert Peyster
P304
P356
10.1001/ARCHNEUR.63.10.NOC60076
P407
P577
2006-10-01T00:00:00Z